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Wanted: A FRAME for Staging Functional
Decline in Older Adults
Clinicians are accustomed to staging diseases in fours.The examples abound: the New York Heart Associa-
tion Class I to IV categories for heart failure, the Global
Initiative for Chronic Obstructive Lung Disease (GOLD),
the four-stage system used for most cancers—all ranging
from mild disease with potential for reversibility in Stage 1
to gravity and irreversibility in Stage 4. Staging systems
provide clinicians with a useful framework to divide
patients into clinically homogeneous groups for the
purposes of prognosis and selection of treatments.
One of the most vexing problems today in caring for
older adults is the lack of a widely recognized model for
categorizing older adults with functional decline that helps
inform prognosis and guide treatment. This challenge of
developing a universal staging system is more difficult in
older adults because of the accumulation of multiple
chronic health conditions and variation in the trajectories
of decline associated with different conditions. Occasion-
ally, one condition dominates the picture because of its
severity (e.g., metastatic cancer, Class IV heart failure), but
more often this is not case, as in individuals with multiple
moderately severe chronic conditions. When multiple condi-
tions coexist, the potential for additive or interactive effects
of these health conditions is greater, further complicating
determination of risk. The current method of counting
number of health conditions is a common but inadequate
substitute for current function and potential for functional
recovery (or decline). All clinicians have patients with long
lists of health problems who are still leading active lives
while other patients with a similar (or shorter) list of health
problems seem to be on the verge of rapidly declining. What
objective ways can one be distinguished from the other?
Certain progress has been made in global measures of
decline for older adults,1–3 but a clinically useful four-stage
measure is still elusive.
When grouping participants in intervention studies, as
in meta-analyses, the need for a globally accepted func-
tional decline measure is also imperative. In this journal,
Dr. Lin and colleagues4 report the challenges they faced
when reviewing the evidence on multifactorial interven-
tions to prevent functional decline in older adults for the
U.S. Preventive Services Task Force. The lack of a widely
recognized model for categorizing older adults into homo-
geneous groups greatly limits the interpretation of the
data.
Older adults vary in their stage of functional decline.
Some older adults may have declined only modestly since
their peak function in the third or fourth decades; they could
be considered “Stage 1.” A Stage 1 individual might be
counseled to stabilize his or her function with regular exer-
cise. Other older adults will have had greater declines. Such
differences are probably also related to future risk of further
decline and death,5–7 with comorbidities probably contrib-
uting to moderate (Stage 2) and severe (Stage 3) risk. Such
individuals might benefit greatly from the specialized multi-
prong interventions that Lin and colleagues review. Last, the
worst stage would be Stage 4, analogous to other staging
systems in its gravity and irreversibility; patients in this stage
have declined too far for even a well-designed multifactorial
intervention to have much effect.
One reason it has not been possible to find clinically sig-
nificant pooled effects of functional decline interventions is
because of mixing of baseline staging. The relationship
between baseline risk and effectiveness is true for most
healthcare interventions, with higher-risk patients benefiting
more. For example, comparing the benefit of the identical
intervention of daily aspirin, prevention of coronary events
is less effective in studies of primary prevention (low risk)
than studies of secondary prevention (high risk). It is likely
that the small pooled effect that Lin and colleagues found is
due to mixing low- and high-risk patients between studies
that varied in the level of risk of their target populations and
that, within studies, participants also varied in their baseline
risk. Furthermore, because how to identify those in Stage 4
global functional decline is not yet understood, it is possible
that inclusion of participants in Stage 4 may have also con-
tributed to not finding a link between intervention and bene-
fit. With single-disease clinical interventions, individuals in
Stage 4 do not receive treatments studied in previous stages;
for example, aspirin therapy has not been studied as an
intervention for individuals with end-stage coronary disease
on a balloon pump.
Geriatric medicine needs a model of functional decline
staging in older adults. A number of measures have been
reviewed in Lin and colleagues, but no single model has
risen to the top in terms of widespread acceptance and use
(e.g., at the level of the New York Heart Association clas-
sification for heart failure). We believe that the critical
factors of such a widely accepted model—let’s call it the
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Easy to apply in clinical practice and clinical interven-
tions.
Based on clinical or administrative data or is potentially
accessible through electronic medical records.
Based primarily on functional status.
Capture whether an individual has a severe, dominant,
index health condition, as opposed to multiple chronic
conditions that are also likely to contribute to probabil-
ity of (or lack of) successful intervention beyond func-
tional status.
The development and refinement of existing classifica-
tion schemes for cancer, heart disease, rheumatoid arthri-
tis, and chronic obstructive pulmonary disease took years
of effort. A similar effort is needed now to develop the
FRAME staging system for functional decline in older
adults. It will not be easy, but without such a staging sys-
tem, we will continue to be frustrated in our ability to
identify interventions to help slow functional decline, to
the detriment of millions of current and future older
adults, at some point including ourselves.
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